Focus research 2022 RADOPT team

Metabolic shift & radioresistance

The MSrGB (Metabolic Shift in radioresistance of Glioblastoma) project, which is coordinated by Prof. Elizabeth Moyal and accredited by the Fondation ARC (PGA) in 2022, aims to study the involvement of metabolic shift in glioblastoma stem cells in adaptation and resistance to radiotherapy. In addition to the RADOPT team, this program involves the IUCT-Oncopole, as well as Prof. Tourneret’s team at IRIT, where new metabolites and their ability to predict relapse after treatment will be identified and studied using deep learning. To find out more

To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here.

Centre de Recherches en Cancérologie de Toulouse

Centre de Recherches contre le Cancer de Toulouse (Oncopole)

Toulouse - FR

Nous contacter

+33 5 82 74 15 75

Nous rejoindre ?

Pin It on Pinterest